Significant elevation in PSA (2027%) was recorded as response to prostate cancer induction (87.23 ± 1.44 ng/mL) compared to the negative control (4.10 ± 0.20 ng/mL) (P ≤ 0.05). This evidence concerns the gene KLK3 and prostate cancer.